UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

The New England journal of medicine, 2014-12, Vol.371 (23), p.2167-2177

2014

Volltextzugriff (PDF)

KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9391

2022

Volltextzugriff (PDF)

Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-08, Vol.36 (22), p.2251-2258

2018

Volltextzugriff (PDF)

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

The New England journal of medicine, 2018-06, Vol.378 (24), p.2288-2301

2018

Volltextzugriff (PDF)

HER2 Deregulation in Lung Cancer: Right Time to Adopt an Orphan?

Clinical cancer research, 2018-06, Vol.24 (11), p.2470-2472

2018

Volltextzugriff (PDF)

Blockage of interleukin-1β with canakinumab in patients with Covid-19

Scientific reports, 2020-12, Vol.10 (1), p.21775-9, Article 21775

2020

Volltextzugriff (PDF)

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

The lancet oncology, 2010-06, Vol.11 (6), p.521-529

2010

Volltextzugriff (PDF)

Identifying and Targeting ROS1 Gene Fusions in Non―Small Cell Lung Cancer

Clinical cancer research, 2012-09, Vol.18 (17), p.4570-4579

2012

Volltextzugriff (PDF)

Prospective Molecular Marker Analyses of EGFR and KRAS From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4113-4120

2011

Volltextzugriff (PDF)

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

Science translational medicine, 2011-09, Vol.3 (99), p.99ra86

2011

Volltextzugriff (PDF)

Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e003027

2022

Volltextzugriff (PDF)

Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1667-1674

2009

Volltextzugriff (PDF)

microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers

Proceedings of the National Academy of Sciences - PNAS, 2015-12, Vol.112 (48), p.14924-14929

2015

Volltextzugriff (PDF)

Experience with erlotinib in the treatment of non-small cell lung cancer

Therapeutic Advances in Respiratory Disease, 2015-08, Vol.9 (4), p.146-163

2015

Volltextzugriff (PDF)

EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects

Cancer treatment reviews, 2012-08, Vol.38 (5), p.416-430

2012

Volltextzugriff (PDF)

Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer

Journal of clinical oncology, 2011-12, Vol.29 (36), p.4789-4795

2011

Volltextzugriff (PDF)

Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN study

Lung cancer (Amsterdam, Netherlands), 2013-11, Vol.82 (2), p.231-237

2013

Volltextzugriff (PDF)

Quadrotor Trajectory Control Based on Energy-Optimal Reference Generator

Drones (Basel), 2024-01, Vol.8 (1), p.29

2024

Volltextzugriff (PDF)

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

Journal for immunotherapy of cancer, 2019-04, Vol.7 (1), p.99-99, Article 99

2019

Volltextzugriff (PDF)

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.316-9, Article 316

2019

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2005-05, Vol.97 (9), p.643-655

2005

Volltextzugriff (PDF)

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

Journal of thoracic oncology, 2010-10, Vol.5 (10), p.1706-1713

2010

Volltextzugriff (PDF)

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results from a Real‐World Population

The oncologist (Dayton, Ohio), 2019-11, Vol.24 (11), p.e1165-e1171

2019

Volltextzugriff (PDF)

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway

Journal of experimental & clinical cancer research, 2022-03, Vol.41 (1), p.91-91, Article 91

2022

Volltextzugriff (PDF)

Correction: Bianchi et al. Quadrotor Trajectory Control Based on Energy-Optimal Reference Generator. Drones 2024, 8, 29

Drones (Basel), 2024-05, Vol.8 (5), p.209

2024

Volltextzugriff (PDF)

1 – 25 von 354

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(309)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(229)
Life Sciences & Biomedicine
(220)
Oncology
(177)
Humans
(175)
Lung Neoplasms - Drug Therapy
(104)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(92)
Female
(85)
Lung Cancer
(82)
Male
(81)
Aged
(79)
Middle Aged
(78)
Lung Neoplasms - Pathology
(76)
Lung Neoplasms - Genetics
(70)
Mutation
(70)
Adult
(63)
Carcinoma, Non-Small-Cell Lung - Genetics
(62)
Respiratory System
(57)
Carcinoma, Non-Small-Cell Lung - Pathology
(56)
Chemotherapy
(56)
Tumors
(53)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges

Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

HER2 Deregulation in Lung Cancer: Right Time to Adopt an Orphan?

Blockage of interleukin-1β with canakinumab in patients with Covid-19

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

Identifying and Targeting ROS1 Gene Fusions in Non―Small Cell Lung Cancer

Prospective Molecular Marker Analyses of EGFR and KRAS From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Cancer

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial

Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers

Experience with erlotinib in the treatment of non-small cell lung cancer

EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects

Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer

Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN study

Quadrotor Trajectory Control Based on Energy-Optimal Reference Generator

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results from a Real‐World Population

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway

Correction: Bianchi et al. Quadrotor Trajectory Control Based on Energy-Optimal Reference Generator. Drones 2024, 8, 29

Suchergebnisse filtern